Rigel Pharmaceuticals, Inc. (RIGL)
25.95
-0.65
(-2.44%)
USD |
NASDAQ |
Mar 13, 16:00
25.92
-0.03
(-0.12%)
After-Hours: 20:00
Rigel Pharmaceuticals Market Cap : 479.38M for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 879.67B |
| Nektar Therapeutics | 1.267B |
| Ironwood Pharmaceuticals, Inc. | 549.51M |
| BioMarin Pharmaceutical, Inc. | 11.25B |
| Amicus Therapeutics, Inc. | 4.512B |
Market Cap Related Metrics
| PE Ratio | 1.372 |
| PS Ratio | 1.660 |
| PEG Ratio | 0.0007 |
| Price to Book Value | 1.224 |
| Price to Free Cash Flow | 6.455 |
| Price | 25.95 |
| Earnings Yield | 72.88% |
| PEGY Ratio | 0.0007 |
| Operating PE Ratio | 3.893 |
| Normalized PE Ratio | 1.372 |